首页|清胰解毒汤方鼻饲加芒硝外敷联合早期肠内营养治疗重症急性胰腺炎的效果分析

清胰解毒汤方鼻饲加芒硝外敷联合早期肠内营养治疗重症急性胰腺炎的效果分析

扫码查看
目的 分析清胰解毒汤方鼻饲加芒硝外敷联合早期肠内营养治疗重症急性胰腺炎(SAP)的效果.方法 100 例重症急性胰腺炎患者,按照治疗方法不同分成观察组和对照组,每组 50 例.观察组给予清胰解毒汤方鼻饲加芒硝外敷联合早期肠内营养治疗,对照组给予早期肠内营养治疗.比较两组炎性因子、免疫功能、不良反应发生情况、胃肠功能恢复用时.结果 治疗前,两组C反应蛋白(CRP)、白细胞介素-1β(IL-1β)、白细胞介素-8(IL-8)比较,差异无统计学意义(P>0.05);治疗后,观察组CRP(26.14±8.75)mg/L、IL-1β(9.02±2.55)pg/ml、IL-8(19.24±3.21)ng/L均明显低于对照组的(36.84±10.69)mg/L、(12.63±2.89)pg/ml、(30.52±3.57)ng/L,差异有统计学意义(P<0.05).治疗前,两组CD3+、CD4+、CD8+比较,差异无统计学意义(P>0.05);治疗后,观察组CD3+(46.25±5.51)%、CD4+(44.21±4.15)%、CD8+(21.25±3.11)%均明显优于对照组的(44.25±4.12)、(42.12±3.59)、(23.25±2.15)%,差异有统计学意义(P<0.05).观察组不良反应发生率 2.00%比对照组的 14.00%低,差异有统计学意义(P<0.05).观察组排气恢复时间(2.41±1.25)d、大便恢复时间(2.51±0.84)d、肠鸣音恢复时间(2.41±0.45)d及腹部不适缓解时间(4.15±0.75)d均明显短于对照组的(4.52±1.69)、(3.59±0.88)、(3.59±0.74)、(7.04±1.22)d,差异有统计学意义(P<0.05).结论 清胰解毒汤方鼻饲加芒硝外敷联合早期肠内营养治疗重症急性胰腺炎的效果显著,病情恢复较快,该治疗方案具有一定推广和应用价值.
Effect analysis of nasal feeding of Qingyi Jiedu Decoction plus external application of mirabilite combined with early enteral nutrition in the treatment of severe acute pancreatitis
Objective To analyze the effect of nasal feeding of Qingyi Jiedu Decoction plus external application of mirabilite combined with early enteral nutrition in the treatment of severe acute pancreatitis(SAP).Methods 100 patients with severe acute pancreatitis were divided into an observation group and a control group according to different treatment methods,with 50 cases in each group.The observation group was given nasal feeding of Qingyi Jiedu Decoction plus external application of mirabilite combined with early enteral nutrition,and the control group was given early enteral nutrition.The inflammatory factors,immune function,occurrence of adverse reactions and recovery time of gastrointestinal function were compared between the two groups.Results Before treatment,there was no significant difference in C-reactive protein(CRP),interleukin-1β(IL-1β)and interleukin-8(IL-8)between the two groups(P>0.05).After treatment,the observation group had CRP of(26.14±8.75)mg/L,IL-1β of(9.02±2.55)pg/ml and IL-8 of(19.24±3.21)ng/L,which were significantly lower than(36.84±10.69)mg/L,(12.63±2.89)pg/ml and(30.52±3.57)ng/L in the control group,and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in CD3+,CD4+and CD8+between the two groups(P>0.05).After treatment,the observation group had CD3+of(46.25±5.51)%,CD4+of(44.21±4.15)%and CD8+of(21.25±3.11)%,which were significantly better than(44.25±4.12),(42.12±3.59)and(23.25±2.15)%in the control group.The difference was statistically significant(P<0.05).The incidence of adverse reactions of 2.00%in the observation group was lower than 14.00%in the control group,and the difference was statistically significant(P<0.05).In the observation group,the recovery time of exhaust was(2.41±1.25)d,the recovery time of bowel movements was(2.51±0.84)d,the recovery time of bowel sound was(2.41±0.45)d,and the relief time of abdominal discomfort was(4.15±0.75)d,which were significantly shorter than(4.52±1.69),(3.59±0.88),(3.59±0.74),and(7.04±1.22)d in the control group,and the difference was statistically significant(P<0.05).Conclusion Nasal feeding of Qingyi Jiedu Decoction plus external application of mirabilite combined with early enteral nutrition has a remarkable effect on the treatment of severe acute pancreatitis,and the recovery is faster.This treatment plan has certain promotion and application value.

Nasal feeding of Qingyi Jiedu DecoctionExternal application of mirabiliteEarly enteral nutritionSevere acute pancreatitis

罗凤球

展开 >

524037 湛江中心人民医院

清胰解毒汤方鼻饲 芒硝外敷 早期肠内营养 重症急性胰腺炎

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(22)